首页> 外文期刊>BioMed research international >Significance of Soluble Lectin-Like Oxidized LDL Receptor-1 Levels in Systemic and Coronary Circulation in Acute Coronary Syndrome
【24h】

Significance of Soluble Lectin-Like Oxidized LDL Receptor-1 Levels in Systemic and Coronary Circulation in Acute Coronary Syndrome

机译:可溶性凝集素样氧化的LDL受体1水平在急性冠脉综合征的全身和冠脉循环中的意义

获取原文
获取原文并翻译 | 示例
           

摘要

Background. Soluble lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) level is a novel biomarker for diagnosis of acute coronary syndrome (ACS); however, this level in the coronary circulation has yet to be examined. Methods. Twenty-seven consecutive patients with ACS and 40 patients with effort angina pectoris (EAP) undergoing percutaneous coronary intervention (PCI) had levels of soluble LOX-1 and LOX-1 index measured in paired blood samples from aorta (Ao) and coronary sinus (CS) just prior to the PCI. Results. We found positive correlations between soluble LOX-1 levels in the Ao and CS in both ACS and EAP patients (P < 0.01, for both). The soluble LOX-1 levels in the Ao and CS were higher in ACS than in EAP patients (P < 0.01, for both). The levels of soluble LOX-1 and LOX-1 index of the CS were significantly greater than those of the Ao in both ACS and EAP patients (P < 0.01, for both). Receiver operating characteristic curves for ACS detection demonstrated high sensitivity and specificity for the soluble LOX-1 and LOX-1 index with no differences between the Ao and CS. Conclusions. The present study showed that circulating soluble LOX-1 originates from coronary circulation and soluble LOX-1 and LOX-1 index are useful biomarkers for ACS.
机译:背景。可溶性凝集素样氧化型低密度脂蛋白受体1(LOX-1)水平是诊断急性冠状动脉综合征(ACS)的新型生物标志物。但是,冠状动脉循环中的这一水平尚待检查。方法。连续接受经皮冠状动脉介入治疗(PCI)的27例ACS患者和40例努力性心绞痛(EAP)患者在主动脉(Ao)和冠状窦的成对血液样本中测得的可溶性LOX-1和LOX-1指数水平( CS)。结果。我们发现ACS和EAP患者的Ao和CS中的可溶性LOX-1水平呈正相关(两者均为P <0.01)。在ACS中,Ao和CS中的可溶性LOX-1水平高于EAP患者(两者均P <0.01)。在ACS和EAP患者中,CS的可溶性LOX-1和LOX-1指数水平均显着高于Ao水平(两者均P <0.01)。用于ACS检测的接收器工作特性曲线显示出对可溶性LOX-1和LOX-1指数的高灵敏度和特异性,而Ao和CS之间没有差异。结论本研究表明循环可溶性LOX-1起源于冠状动脉循环,可溶性LOX-1和LOX-1指数是ACS的有用生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号